Prognostic factors in early glottic carcinoma implications for treatment

Tumori

Volumn 91, Issue 2, 2005, Pages 182-187

  Nur, Demiral Ayse ^a,b   Oguz, Cetinayak ^a   Kemal, Erdag Taner ^a   Ferhat, Eyiler ^a   Sülen, Sarioglu ^a   Emel, Ada ^a   Münir, Kinay ^a   Ann, Cooper Sen Rachel ^a   Mehmet, Sen ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Early glottic carcinoma; Prognostic factor

Indexed keywords

ADULT; AGED; ANTERIOR COMMISSURE; ARTICLE; CANCER CONTROL; CANCER INVASION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS; RADIATION DOSE; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; VOCAL CORD;

EID: 18944398916     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160509100215     Document Type: Article

References (49)

1. Jin J, Liao Z, Gao L, Huang X, Xu G: Analysis of prognostic factors for T(1)N(0)M(0) glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy of Medical Sciences. Int J Radiat Oncol Biol Phys, 54: 471-478, 2002.
2. Marshak G, Brenner B, Shvero J, Shapira J, Ophir D, Hochman I, Marshak G, Sulkes A, Rakowsky E: Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients. Int J Radiat Oncol Biol Phys, 43: 1009-1013, 1999.
3. Reddy SP, Mohideen N, Marra S, Marks JE: Effect of tumor bulk on local control and survival of patients with T1 glottic cancer. Radiother Oncol, 47: 161-166, 1997.
4. O'Sullivan B, Mackillop W, Gilbert R, Gaze M, Lundgren J, Atkinson C, Wynne C, Fu H: Controversies in the management of laryngeal cancer: results of an international survey of patterns of care. Radiother Oncol, 31: 23-32, 1994.
5. Lusinchi A, Dube P, Wibault P, Kunkler I, Luboinski B, Eschwege F: Radiation therapy in the treatment of early glottic carcinoma: the experience of Villejuif. Radiother Oncol, 15: 313-319, 1989.
6. Mendenhall WM, Parsons JT, Million RR: Management of T1 and T2 squamous cell carcinoma of the glottic larynx. Mayo Clin Proc, 67: 703-705, 1992.
7. Sakata K, Aoki Y, Karasawa K, Hasezawa K, Muta N, Nakagawa K, Terahara A, Onogi Y, Sasaki Y, Akanuma A: Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control. Int J Radiat Oncol Biol Phys, 30: 1059-1064, 1994.
8. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW: T1-2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol, 19: 4029-4036, 2001.
9. Hermans R, Feron M, Bellon E, Dupont P, Van den Bogaert W, Baert AL: Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability. Int J Radiat Oncol Biol Phys, 40: 553-557, 1998.
10. Warde P, O'Sullivan B, Bristow RG, Panzarella T, Keane TJ, Gullane PJ, Witterick IP, Payne D, Liu FF, McLean M, Waldron J, Cummings BJ: T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys, 41: 347-353, 1998.
11. Skladowski K, Tarnawski R, Maciejewski B, Wygoda A, Slosarek K: Clinical radiobiology of glottic T1 squamous cell carcinoma. Int J Radiat Oncol Biol Phys, 43: 101-106, 1999.
12. Holland JM, Arsanjani A, Liem BJ, Hoffelt SC, Cohen JI, Stevens KR Jr: Second malignancies in early stage laryngeal carcinoma patients treated with radiotherapy. J Laryngol Otol, 116: 190-193, 2002.
13. Burke LS, Greven KM, McGuirt WT, Case D, Hoen HM, Raben M: Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. Int J Radiat Oncol Biol Phys, 38: 1001-1006, 1997.
14. Kim RY, Marks ME, Salter MM: Early-stage glottic cancer: importance of dose fractionation in radiation therapy. Radiology, 182: 273-275, 1992.
15. Fein DA, Lee WR, Hanlon AL, Ridge JA, Langer CJ, Curran WJ Jr, Coia LR: Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol, 13: 2077-2083, 1995.
16. Narayana A, Vaughan AT, Kathuria S, Fisher SG, Walter SA, Reddy SP: P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. Int J Radiat Oncol Biol Phys, 46: 21-26, 2000.
17. Miyaguchi M, Olofsson J, Hellquist HB: Expression of epidermal growth factor receptor in glottic carcinoma and its relation to recurrence after radiotherapy. Clinical Otolaryngology, 16: 466-469, 1991.
18. Demiral AN, Sarioglu S, Birlik B, Sen M, Kinay M: Prognostic significance of EGF receptor expression in early glottic cancer. Auris Nasus Larynx, 31: 417-424, 2004.
19. Small W Jr, Mittal BB, Brand WN, Shetty RM, Rademaker AW, Beck GG, Hoower SV: Results of radiation therapy in early glottic carcinoma: multivariate analysis of prognostic and radiation therapy variables. Radiology, 183: 789-794, 1992.
20. Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, Krieg RM, Phillips TL: Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys, 39: 115-126, 1997.
21. Yu E, Shenouda G, Beaudet MP, Black MJ: Impact of radiation therapy fraction size on local control of early glottic carcinoma. Int J Radiat Oncol Biol Phys, 37: 587-591, 1997.
22. Fein DA, Lee WR, Hanlon AL, Ridge JA, Curran WJ, Coia LR: Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx? Int J Radiat Oncol Biol Phys, 34: 823-831, 1996.
23. Zouhair A, Azria D, Coucke P, Matzinger O, Bron L, Moeckli R, Do HP, Mirimanoff RO, Ozsahin M: Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension. Strahlenther Onkol, 180: 84-90, 2004.
24. Shvero J, Hadar T, Segal K, Yaniv E, Marshak G, Feinmesser R: T1 glottic carcinoma involving the anterior commissure. Eur J Surg Oncol, 20: 557-560, 1994.
25. Sobin LH, Wittekind C: TNM classification of malignant tumors, 5th ed, pp 33-37, John Wiley & Sons Inc, New York, 1997.
26. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc, 53: 457-461, 1958.
27. Altman DG: Principles of statistical analysis. In: Practical statistics for medical research, 1st ed, Altman DG (Ed), pp 152-178, Chapman & Hall, London, 1991.
28. Dawson B, Trapp RG: Analyzing research questions about survival. In: Basic & clinical biostatistics, 3rd ed, Dawson B, Trapp RG (Eds), p 218, Lange Medical Books/Mc Graw Hill, New York, 2001.
29. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer, 35: 1-39, 1977.
30. Cox DR: Regression models and life-tables. J R Stat Soc, 34: 187-220, 1972.
31. Rudoltz MS, Benammar A, Mohiuddin M: Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Phys, 26: 767-772, 1993.
32. Stevenson JM, Juillard GJ, Selch MT: Stages 1 and 2 epidermoid carcinoma of the glottic larynx: involvement of the anterior commissure. Radiology, 182: 797-799, 1992.
33. Raitiola H, Wigren T, Pukander J: Radiotherapy outcome and prognostic factors in early glottic carcinoma. Auris Nasus Larynx, 27: 153-159, 2000.
34. Kanonier G, Fritsch E, Rainer T, Thumfart WF: Radiotherapy in early glottic carcinoma. Ann Otol Rhinol Laryngol, 105: 759-763, 1996.
35. Dubben HH, Thames HD, Beck-Bornholdt HP: Tumor volume: a basic and specific response predictor in radiotherapy. Radiother Oncol, 47: 167-174, 1998.
36. Fein DA, Mendenhall WM, Parsons JT, Million RR: T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control. Int J Radiat Oncol Biol Phys, 25: 605-611, 1993.
37. Benninger MS, Gillen J, Thieme P, Jacobson B, Dragovich J: Factors associated with recurrence and voice quality following radiation therapy for T1 and T2 glottic carcinomas. Laryngoscope, 104: 294-298, 1994.
38. Sombeck MD, Kalbaugh KJ, Mendenhall WM, Parsons JT, Smith SA, Million RR, Palta JR: Radiotherapy for early vocal cord cancer: a dosimetric analysis of 60CO versus 6 MV photons. Head Neck, 18: 167-173, 1996.
39. Dinshaw KA, Sharma V, Agarwal JP, Ghosh S, Havaldar R: Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications. Int J Radiat Oncol Biol Phys, 48: 723-735, 2000.
40. Parsons JT, Greene BD, Speer TW, Kirkpatrick SA, Barhorst DB, Yanckowitz T: Treatment of early and moderately advanced vocal cord carcinoma with 6-MV X-rays. Int J Radiat Oncol Biol Phys, 50: 953-959, 2001.
41. Devineni VR, King K, Perez C: Early glottic carcinoma treated with radiotherapy: Impact of treatment energy on success rate. Int J Radiat Oncol Biol Phys, 24: 106, 1992.
42. Izuno I, Sone S, Oguchi M, Kiyono K, Takei K: Treatment of early vocal cord carcinoma with Co60 gamma rays, 8/10 MV X rays, or 4 MV X rays: are the results different? Acta Oncol, 29: 637-639, 1990.
43. Garden AS, Forster K, Wong PF, Morrison WH, Schechter NR, Ang KK: Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment? Int J Radiat Oncol Biol Phys, 55: 322-328, 2003.
44. Fowler JF: Fractionation and glottic carcinoma. Int J Radiat Oncol Biol Phys, 39: 1-2, 1997.
45. Hendry JH, Roberts SA, Slevin NJ, Keane TJ, Barton MB, Agren-Cronqvist A: Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada. Radiother Oncol, 31: 14-22, 1994.
46. Schwaibold F, Scariato A, Nunno M, Wallner PE, Lustig RA, Rouby E, Gorshein D, Wenger J: The effect of fraction size on control of early glottic cancer. Int J Radiat Oncol Biol Phys, 14: 451-454, 1988.
47. Roberts TJ, Epstein B, Lee DJ: Second neoplasms in patients with carcinomas of the vocal cord: incidence and implications for survival. Int J Radiat Oncol Biol Phys, 21: 583-589. 1991.
48. Fujita M, Rudoltz MS, Canady DJ, Patel P, Machtay M, Pittard MQ, Mohiuddin M, Regine WF: Second malignant neoplasia in patients with Tl glottic cancer treated with radiation. Laryngoscope, 108: 1853-1855, 1998.
49. Di Martino E, Sellhaus B, Hausmann R, Minkenberg R, Lohmann M, Esthofen MW: Survival in second primary malignancies of patients with head and neck cancer. J Laryngol Otol, 116: 831-838, 2002.